7 completed, 1 terminated, 1 unknown. 5 Phase 2, 2 Phase 1, 2 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Terminated 1, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
Follow Placebo Topical Gel: new trials by email Literature Review of Placebo Topical Gel trials Research Report on Placebo Topical Gel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Home-Based Quadriceps Isometric Exercise for Knee Osteoarthritis Pain Placebo Topical Gel, Cannabidiol (CBD) Topical Gel, Arnica montana Topical Gel - Older Adults (60 - 85 Years Old), OA Knee | Not applicable | Completed | Universidad del Valle de México, Campus Cuernavaca | 50 | 2025-09-01 | 2026-03-03 |
| Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer 5% Bisphosphocin Topical Gel, Placebo Topical Gel, 10% Bisphosphocin Topical Gel - Chronic Diabetic Foot Ulcers | Phase 2 | Terminated | Lakewood-Amedex Inc | 3 | 2022-03-11 | 2024-01-30 |
| Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study Pro-ocular™ Topical Gel, Placebo Topical Gel - Dry Eye Syndrome, Keratoconjunctivitis Sicca | Phase 2 | Unknown | PharmaDax Inc. | 80 | 2021-05-20 | 2021-05-14 |
| Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT. Pro-ocular™ topical gel, Placebo topical gel - Chronic Ocular Graft-versus-host Disease | Phase 2 | Completed | Glia, LLC | 33 | 2019-10-17 | 2025-05-06 |
| Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical Gel CLM2 topical gel, Placebo topical gel - Contact Lens Discomfort, Contact Lens-induced Corneal Disorder | Phase 2 | Completed | Glia, LLC | 30 | 2019-06-27 | 2023-03-24 |
| The Effect of Topical Doxycycline Gel on HbA1c in Patients With Type 2 Diabetes Mellitus(DM) ® Doxycycline Group, placebo topical gel - Diabetes Mellitus With Periodontal Disease | Phase 2 / Phase 3 | Completed | Amirhossein Farahmand | 24 | 2015-01-01 | 2019-07-05 |
| Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis Naftifine Hydrochloride Gel 2%, Naftin® Gel 2%, Placebo Topical Gel - Tinea Pedis | Phase 1 | Completed | Sun Pharmaceutical Industries, Inc. | 1519 | 2014-06-27 | 2018-09-06 |
| A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel, Duac® Topical Gel, Placebo Topical Gel - Acne Vulgaris | Phase 1 | Completed | Sun Pharmaceutical Industries, Inc. | 650 | 2012-09-01 | 2014-01-22 |
| A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo Oxybutynin topical gel, Placebo topical gel - Overactive Bladder | Phase 3 | Completed | Watson Pharmaceuticals | 789 | 2006-06-01 | 2010-05-10 |
Acne Vulgaris (1) · Agnosia (1) · Cardiovascular Diseases (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Diabetic Angiopathies (1) · Diabetic Foot (1) · Diabetic Neuropathies (1) · Dry Eye Syndromes (1) · Endocrine System Diseases (1) · Foot Ulcer (1) · Glucose Metabolism Disorders (1) · Keratoconjunctivitis Sicca (1) · Leg Ulcer (1) · Metabolic Diseases (1)
Glia, LLC (2) · Sun Pharmaceutical Industries, Inc. (2) · Amirhossein Farahmand (1) · Lakewood-Amedex Inc (1) · PharmaDax Inc. (1) · Universidad del Valle de México, Campus Cuernavaca (1) · Watson Pharmaceuticals (1)
United States (4) · Mexico (1) · Taiwan (1)
Kim Caramelli, MS (1) · Meng C. Lin, OD,PhD,FAAO (1) · Peichun Kuo (1) · Sumita Paul, MD, MPH (1) · Zhonghui K Luo, MD, PhD (1)